Navigation Links
The Queen Of All Contraceptives Released

A few months back, the Food and Drug Administration approved a new birth control pill, Lybrel. It is as effective at preventing pregnancy as the other pills already in the market , but overrides them with one advantage: Women who take it will never get their periods.

Lybrel is landing on pharmacy shelves this month. Now menstruation may never be the same- it may disappear altogether.

Already the first few volleys in this battle have been exchanged, a barrage of advertising and research highlighting the debilitating effects of periods and the joys of menstrual suppression.

Women libbers may argue- periods and their mood swings are bad for family values (cranky mothers), bad for womens health, bad for the fashion industry and bad for the economy (leave taken on grounds of period pain).

In a presentation by Lybrels maker, Wyeth, to investors and analysts last October, Dr. Ginger D. Constantine, the companys therapeutic director for womens health, laid the groundwork. Citing company-backed studies, she reported that menstruating women feel less effective at work and take more sick days. Not only that, but they dont exercise and they wear dark clothes more often, she said.

Suddenly, news articles are weighing the pros and cons of the monthly cycles. Yet, history shows that such debates are, well, cyclical. In the 1870s and 1880s, when Americans were debating the value of higher education for women, a flurry of research asserted that womens cycling constitutions made them unfit for sustained mental and physical labor.

Henry Maudsley, a British doctor, reflected popular opinion when he observed that menstruation doomed girls to failure in college. Comparing boys and girls, Maudsley insisted in an article, was not a question of two bodies and minds that are in equal physical condition, but of one body and mind capable of sustained and regular hard labor, and of another body and mind which one quarter
'"/>




Page: 1 2

Related medicine news :

1. Beauty Queens Urge On The Importance Of Maintaining Bone Integrity
2. Queensland Bans OTC Sales Of Cold And Flu Drugs
3. Queensland Opposition not happy over hiring consultancy
4. The mystery of the bulge in North Queenslanders
5. Queensland : Call for improved mental health services
6. Surgery cancellations in Queens land Hospital
7. Mammograms in Queensland Reviewed
8. Queensland Government to Meet its Medical Targets
9. Meningococcal Scare in Queensland
10. Medical Person As Health Minister To Improve Queenslands Health System
11. Dentist Tested Positive For HIV - Queensland Health To Screen Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Queen All Contraceptives Released

(Date:5/16/2008)... HAE: TSX, MONTREAL...ation,(TSX:HAE), a specialty bio-therapeutics comp...rcialization, announced today that its Chairman of...li, will present at the,upcoming Rodman & Renshaw ..., May 20, 2008 in the Zephyr Room at Le Meridien B...
(Date:5/16/2008)... SAO PAULO, Brazil, May 16 /PRNewswire-FirstCall/ ...rs: TEMP3.SA; Bloomberg: TEMP3 BZ), a leading,prov... benefit plans and,specialized assistance services...r of 2008. The operating and financial information...d, is presented in Brazilian Reais and in,accordan...
(Date:5/15/2008)...PHILADELPHIA) Combining natural organic atoms wit...ute have developed a new type of enzyme inhibitor ...ys a key role in cancer development. , Based on...es the way for developing new ways to treat cancer...leads to uncontrolled tumor growth. , Details of...
(Date:5/15/2008)... HARBIN, China, May 15 /Xinhua-PRNewswire-FirstCal...tin Board: CYXI) ("China Yingxia" or "the,Company"...y engaged in the,development, manufacture and dist...plements, and personal care products in the People...inancial results for the first,quarter ended March...
Breaking Medicine News(10 mins):Health News:Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 2Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 4Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 5Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 7Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 8Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 9
... - how beneficial traits accumulate in natural pop...he past, two theories have addressed this problem....t confer a cost to their bearer can become common ...y "hitch a ride" with fitter genes that are being ...
...encourage patients with sexually transmitted infec...nd, in some cases, provide home testing kits or dr...dy on bmj.com. Partner notification is an importa...lly transmitted infections, but the stigma attache...
... developed a Vitamin D pill that could give a long...ge of prostrate cancer when given along with chemo...y US drug company Novacea lived for an average of ...ing chemotherapy drug taxotere alone, reported the...
...why we shed tears. But exactly what our tears are ... new study sheds some light on the complex design ...ll tear film, which is made up of three distinct, ... layer – what we normally think of as tears when w...
Other Medicine News:Health News:Study Explains How Costly Traits Evolve 2Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 2Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 3
(Date:5/15/2008)... France, May 15 /- Cerenis,Therapeuti...ompany,developing HDL-related compounds for the tr...today announced that it has completed a Phase I,cl...d product candidates.,CER-002 is a peroxisome prol...agonist in development for the treatment of cardio...
(Date:5/15/2008)... CenterWatch, a publishing and,information service...l,trials, finds that investigative sites are requi...) systems. More than 75% of respondents to a recen...trained on three or more,EDC systems. In addition,...eir EDC training had improved., State of the Clin...
(Date:5/15/2008)...wire-FirstCall/ -- Novavax, Inc. (Nasdaq:,NVAX) to...the Phase I/IIa,study of its pandemic influenza va...cts. Favorable interim results from the first phas...70 healthy adult volunteers, were,reported in Dece... vaccine,is well tolerated and immunogenic at the ...
(Date:5/15/2008)... Plan Positions Blue Cross Blue Shield of Mic...rt from HealthLeaders-Inter...ealthLeaders-InterStudy, the,leading provider of m...he,economy continues to stagnate in Michigan, Blue...uipped of all of its competitors to weather the,ec...
Breaking Medicine Technology:Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 1Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 3Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 4Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 5Phlo Reports Sharp Revenue Increase 3441 1Phlo Reports Sharp Revenue Increase 3441 2Cancer Cure Coalition Proposes Major Changes at the FDA 1404 1Cancer Cure Coalition Proposes Major Changes at the FDA 1404 2Cancer Cure Coalition Proposes Major Changes at the FDA 1404 3Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 1Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 2Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 3Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 4
The proven daily wear spherical soft contact lens.
Surevue brand contact lenses deliver exceptional overall performance in a contact lens since they're easy to use and offer great comfort.
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis.
The Naugle uses reflection mirrors to measure the position of the globe accurately, even after tumor removal or thyroid decompression. It delivers fast, reproducible results. The Naugle is easy to ha
Medicine Products: